NCT00168181View on ClinicalTrials.gov

Trial Comparing Oral Pilocarpine (Salagen) Versus Submandibular Salivary Gland Transfer Protocol, For the Prevention of Radiation (XRT) Induced Xerostomia in Head and Neck Cancer Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

220

Participants

Timeline

Start Date

April 30, 2002

Study Completion Date

April 30, 2008

Conditions
CancerHead and Neck Cancer
Interventions
PROCEDURE

Submandibular gland Transfer

DRUG

Salagen

Trial Locations (1)

T6G 1Z2

Cross Cancer Institute, Edmonton

Sponsors
All Listed Sponsors
collaborator

CancerCare Manitoba

OTHER

collaborator

Jewish General Hospital

OTHER

collaborator

Newfoundland Cancer Treatment & Research Foundation

UNKNOWN

collaborator

Notre-dame Hospital

UNKNOWN

collaborator

Ottawa Hospital Research Institute

OTHER

lead

Alberta Health services

OTHER